Latvia Antiinfective Medicine Sales is set to reach $93.07 Million by 2026 from $80.52 Million, is expected to jump by 5.5% per year. Germany, South Korea and Italy respectively were numbers 2, 3 and 4 in this ranking.
How does Latvia perform in Anti-Infective?
Hormones in Dosage Except Contraceptives and Antibiotics Market Size Value in Latvia
- US Dollars
- 2011 to 2023
- ReportLinker Research
Hormones in Dosage Except Contraceptives and Antibiotics Market Size Value Per Capita in Latvia
- US Dollars
- 2011 to 2023
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research